Suchergebnisse - "Kaki, Takahiro"

PubPharm (10)

1

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration : A randomized phase II trial

enthalten in: Cancer medicine | 2024

von Murakami, E. | Akamatsu, H. | Teraoka, S. | +15

2

A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients

enthalten in: Journal of pain and symptom management | 2024

von Takase, E. | Akamatsu, H. | Teraoka, S. | +17

3

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration : A randomized phase II trial

enthalten in: Cancer Medicine | 2024

von Murakami, E. | Akamatsu, H. | Teraoka, S. | +15

4

Adjacent angle size correlates with diagnostic sensitivity of endobronchial ultrasonography with a guide sheath

enthalten in: Journal of thoracic disease | 2023

von Kato, M. | Fujimoto, D. | Kaki, T. | +9

5

Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan

enthalten in: Medicina (Kaunas, Lithuania) | 2022

von Tamura, S. | Kaki, T. | Niwa, M. | +11

6

Effects of individualized target setting on step count in Japanese patients with chronic obstructive pulmonary disease : a pilot study

enthalten in: Advances in respiratory medicine | 2021

von Sasaki, S. | Minakata, Y. | Azuma, Y. | +3

7

Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan : A Single-Center Case Series

enthalten in: The Journal of infectious diseases | 2020

von Kobayashi, K. | Kaki, T. | Mizuno, S. | +3

8

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer

enthalten in: The oncologist | 2020

von Akamatsu, H. | Murakami, E. | Oyanagi, J. | +16

9

Correlation of Immune-Related Adverse Events and Effects of Pembrolizumab Monotherapy in Patients with Non-Small Cell Lung Cancer

enthalten in: Lung Cancer (Auckland, N.Z.) | 2020

von Noguchi, S. | Suminaga, K. | Kaki, T. | +6

10

Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer

enthalten in: The oncologist | 2020

von Akamatsu, H. | Murakami, E. | Oyanagi, J. | +16

1
[1]